論文・技術情報追加のお知らせ

①Developing an Artificial Intelligence-Guided Signal Detection in the Food and Drug Administration Adverse Event Reporting System (FAERS): A Proof-of-Concept Study Using Galcanezumab and Simulated Data.

ガルカネズマブを例とした、AIベースの不均衡解析フレームワーク開発、検証研究

対象DB：FAERS

②A Pharmacoepidemiological Study of Myocarditis and Pericarditis Following the First Dose of mRNA COVID-19 Vaccine in Europe.

欧州における、COVID-19ワクチン初回投与時の心筋炎・心膜炎報告の評価研究

対象DB：EudraVigilance

③Suspected cutaneous adverse drug reactions reported with traditional medicines: analysis of data for United Nations Asia region from WHO VigiBase.

伝統薬に関連する皮膚有害事象の調査研究

対象DB：VigiBase

④Association of depression and suicidal behaviour reporting with HIV integrase inhibitors: a global pharmacovigilance study.

HIVインテグラーゼ阻害剤によるうつ病および自殺行動の関連性調査研究

対象DB：VigiBase

⑤Hypoxia associated with dihydropyridine calcium channel inhibitors: a pharmacovigilance study in VigiBase(R).

ジヒドロピリジン系カルシウム拮抗薬と低酸素症の関連性評価研究

対象DB：VigiBase

⑥Drug-related catatonia in youths: real-world insights from the WHO Safety Database.

青少年における薬物性緊張病に関するリスク調査研究

対象DB：VigiBase

⑦Association between immune checkpoint inhibitor-induced myocarditis and concomitant use of thiazide diuretics.

チアジド系利尿剤併用による、ICI誘発性心筋炎への影響評価研究

対象DB：VigiBase